Bismuth subcitrate potassium / Metronidazole / Tetracycline hydrochloride
Key facts
| Active substance |
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/74/2009
|
| PIP number |
Bismuth subcitrate potassium / Metronidazole / Tetracycline hydrochloride
|
| Pharmaceutical form(s) |
Capsule
|
| Condition(s) / indication(s) |
Helicobacter pylori infection
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Axcan Pharma SA
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|